Literature DB >> 619805

Studies in pharmacokinetics and tolerance of substances temporarily retained in the liver by microsphere embolization.

B Lindell, K F Aronsen, B Nosslin, U Rothman.   

Abstract

Earlier investigation has shown that a temporary arrest of arterial blood flow can be achieved by embolization with degradable microspheres. This study was made to investigate the change in pharmacokinetics, and drug tolerance which takes place when a substance is retained in the liver by a microsphere embolization. 14C-labelled inulin and 5-fluorouracil were studied. The administration of these substances with microspheres led to a delay in their systemic distribution. Furthermore there was an increased tolerance to 5-fluoro-uracil, probably due to a prolonged first pass effect when the substance was temporarily retained in the liver by a microsphere embolization.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 619805      PMCID: PMC1396395          DOI: 10.1097/00000658-197801000-00018

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  6 in total

1.  THE PHYSIOLOGIC DISPOSITION OF 5-FLUOROURACIL AND 5-FLUORO-2'-DEOXYURIDINE IN MAN.

Authors:  B CLARKSON; A O'CONNOR; L WINSTON; D HUTCHISON
Journal:  Clin Pharmacol Ther       Date:  1964 Sep-Oct       Impact factor: 6.875

2.  Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893).

Authors:  J L Cohen; L E Irwin; G J Marshall; H Darvey; J R Bateman
Journal:  Cancer Chemother Rep       Date:  1974 Sep-Oct

Review 3.  Route of administration and drug disposition.

Authors:  M Gibaldi; D Perrier
Journal:  Drug Metab Rev       Date:  1974       Impact factor: 4.518

4.  Determination of 5-fluorouracil (NSC-19893) plasma levels in rats and man by isotope dilution-mass fragmentography.

Authors:  C Finj; W Sadée
Journal:  Cancer Chemother Rep       Date:  1975 Mar-Apr

5.  Temporary interruption of regional blood flow combined with local hyperthermia for cancer chemotherapy.

Authors:  T Baba; K Aoki; Y Kidera; M Kimura; T Kanematsu
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

6.  The biliary excretion of 3H-inulin and 3H-terbutaline in the unanesthetized rat.

Authors:  H Eriksson; W Hellström; A Ryrfeldt
Journal:  Acta Physiol Scand       Date:  1975-09
  6 in total
  8 in total

1.  Optimization of nanoparticle drug microcarrier on the pharmacokinetics of drug release: a preliminary study.

Authors:  E Y K Ng; W K Ng; S S Chiam
Journal:  J Med Syst       Date:  2008-04       Impact factor: 4.460

2.  Effect of microspheres in intra-arterial chemotherapy. A study of arterio-venous shunting and passage of a labelled marker.

Authors:  H Starkhammar; L Håkansson; O Morales; J Svedberg
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

Review 3.  Therapy of bladder cancer.

Authors:  K H Bichler; S Halim
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

4.  A gamma camera method to monitor the use of degradable starch microspheres in hepatic arterial chemotherapy.

Authors:  A Britten; A Flowerdew; T Hunt; I Taylor; D Ackery; J Fleming
Journal:  Eur J Nucl Med       Date:  1989

5.  Effects of multimodal treatment and hyperthermia on hepatic tumors.

Authors:  Y Tanaka; K Yamamoto; T Murata; K Nagata
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 6.  Clinical pharmacokinetic advantages of new drug delivery methods for the treatment of liver tumours.

Authors:  J H Anderson; H W Warren; C S McArdle
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

7.  Increasing hepatic arterial flow to hypovascular hepatic tumours using degradable starch microspheres.

Authors:  D Chang; S A Jenkins; S J Grime; D M Nott; T Cooke
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

8.  Intravital microscopic research of microembolization with degradable starch microspheres.

Authors:  Micaela Ebert; Juergen Ebert; Gerd Berger
Journal:  J Drug Deliv       Date:  2013-11-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.